{"nct_id":"NCT02918331","title":"A Study of JNJ-54767414 (Daratumumab) in Combination With Lenalidomide and Dexamethasone in Japanese Participants With Previously Untreated Multiple Myeloma Who Are Ineligible for High-dose Therapy and Autologous Stem Cell Transplantation","status":"COMPLETED","status_verified_date":"2025-01","start_date":"2016-09","start_date_type":"ACTUAL","primary_completion_date":"2017-10","primary_completion_date_type":"ACTUAL","completion_date":"2020-03","completion_date_type":"ACTUAL","phases":["PHASE1"],"tickers":["JNJ"]}